This move is archived. Current quotes and coverage live on the stock page.
Follow BHC
Bausch Health Companies Inc faced a notable setback in its stock performance, declining by over 3% in yesterday's trading session.
In a disappointing turn of events, Bausch Health Companies Inc (BHC.TO) saw its stock price drop by 3.21% yesterday, closing at CA$8.74. This decline comes amidst mixed sentiment regarding the company's financial outlook and recent developments.
Advertisement
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.22B
52W high
$11.08
52W low
$6.10
1W change
+5.78%
Beta
0.37
Analyst Price Targets
Based on analyst covering BHC · as of Sep 17, 2026
Wall Street analysts forecast BHC stock price to fall 18.5% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-18.5% Upside
Current Price
C$8.60
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
36.9%
Annualized
90-Day Vol
65.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$10.28
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.13 | C$8.04 – C$10.37 |
| 60 trading days | C$9.69 | C$8.09 – C$11.60 |
| 90 trading days | C$10.28 | C$8.25 – C$12.82 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Bausch Health's stock struggles to maintain upward momentum, reflecting broader concerns about its profitability and market position.
Bausch Health's stock fell by 3.21% yesterday
The market capitalization of Bausch Health now stands at approximately CA$3.37 billion, reflecting investor skepticism amidst ongoing operational challenges.
Bull case
Despite the recent drop, some analysts see improving earnings estimates for Bausch Health. This could signal a chance for recovery if the company can leverage its strengths in the pharmaceutical sector.
Bear case
The stock's recent performance raises concerns about its long-term viability. With a negative profit margin and no P/E ratio, there are significant challenges ahead for generating sustainable profits.
Recent Performance Overview
Advertisement
Bausch Health's stock performance has been under scrutiny, particularly following its 3.21% decline yesterday. This drop reflects investor concerns about the company's ability to improve its financial performance, especially given its negative profit margin of -10.12%. The market is reacting to both internal challenges and external pressures within the pharmaceutical industry.
Market Reactions and Future Outlook
The recent decline in Bausch Health's stock price has led to increased skepticism among investors. While some analysts point to the potential for recovery due to improving earnings estimates, the lack of a P/E ratio and ongoing profitability issues create a challenging environment. Investors may want to keep an eye on the company's upcoming earnings reports and strategic initiatives to better understand its potential for recovery.
Conclusion: A Cautious Approach
Given the recent stock performance and underlying financial challenges, investors should approach Bausch Health with caution. While there are signs of potential improvement in earnings estimates, the current market sentiment suggests that significant hurdles remain before the stock can regain its footing. For more detailed insights, check out our analysis on BHC.TO.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
